(Q30976921)

27 June 2017

title

Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants (English)

1 reference

27 June 2017

author

Marjorie Robert-Guroff

13

object named as

Marjorie Robert-Guroff

1 reference

27 June 2017

Jun Zhao

1

1 reference

27 June 2017

Yuanmei Lou

2

1 reference

27 June 2017

Joel Pinczewski

3

1 reference

27 June 2017

Nina Malkevitch

4

1 reference

27 June 2017

Kristine Aldrich

5

1 reference

27 June 2017

V S Kalyanaraman

6

1 reference

27 June 2017

David Venzon

7

1 reference

27 June 2017

Bo Peng

8

1 reference

27 June 2017

L Jean Patterson

9

1 reference

27 June 2017

Yvette Edghill-Smith

10

1 reference

27 June 2017

Ruth Woodward

11

1 reference

27 June 2017

George N Pavlakis

12

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

27 June 2017

1 reference

27 June 2017

volume

21

1 reference

27 June 2017

issue

25-26

1 reference

27 June 2017

page(s)

4022-4035

1 reference

Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Loss of mucosal CD4 lymphocytes is an early feature of HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Berlin Diarrhea/Wasting Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Selective depletion of rectal lamina propria rather than lymphoid aggregate CD4 lymphocytes in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Intestinal intraepithelial lymphocytes are primed for gamma interferon and MIP-1beta expression and display antiviral cytotoxic activity despite severe CD4(+) T-cell depletion in primary simian immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Progress in the development of an HIV-1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Induction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzees.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Naturally occurring V1-env region variants mediate simian immunodeficiency virus SIVmac escape from high-titer neutralizing antibodies induced by a protective subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Coexpression of the simian immunodeficiency virus Env and Rev proteins by a recombinant human adenovirus host range mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Selective extraction of polyoma DNA from infected mouse cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Use of cryopreserved lymphocytes for assessment of the immunological effects of interferon therapy in renal cell carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Assessment of immune function by lymphoproliferation underestimates lymphocyte functional capacity in HIV patients treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

ELISPOT assay for detection of peptide specific interferon-gamma secreting cells in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Induction of mucosal immunity with a replication-defective adenoviral recombinant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Prevalence of antibodies to adenovirus serotypes 4 and 7 among unimmunized US Army trainees: results of a retrospective nationwide seroprevalence survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900266-4

7 January 2021

10.1016/S0264-410X(03)00266-4

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/s4qvj5yi75b6nfy3pikb4paniu

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_s4qvj5yi75b6nfy3pikb4paniu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/s4qvj5yi75b6nfy3pikb4paniu

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/s4qvj5yi75b6nfy3pikb4paniu

1 reference

30 July 2022